Hormone therapy for endometriosis and surgical menopause
reference-entry
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This Cochrane review protocol outlines the plan to examine pain recurrence in women with endometriosis who used hormone therapy after surgical menopause.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review aims to look at pain recurrence for women with endometriosis who used hormone therapy post surgical menopause.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- A Comparison of the Skeletal Effects of Goserelin and Danazol in Premenopausal Women with Endometriosis via openalex
- Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis via openalex
- Endometriosis in Adolescents via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Endometriosis: the present and the future—an overview of treatment options via openalex
- Epidemiology of endometriosis among parous women via openalex
- Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
- Is rectovaginal endometriosis a progressive disease? via openalex
- Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis via openalex
- Recto vaginal septum adenomyotic nodules: a series of 500 cases via openalex
- Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl) via openalex
- The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- Treatment of endometriosis via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. via openalex
- W6770085570 via openalex
- W6659236527 via openalex
- W6655287665 via openalex
- W6717624033 via openalex
Cited by (3)
- Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
- Research Trends of Acupuncture Therapy on Chronic Pelvic Pain Syndrome from 2000 to 2022: A Bibliometric Analysis 2023
- Endometriose en pijn: een overzicht met argumentatie voor een individuele en multidisciplinaire aanpak 2021
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK